Abstract
BackgroundIt is usually very problematic to initiate urate-lowering therapy in patients with chronic tophaseous gout resistant to NSAIDs and colchicine therapy[1]. In such cases canakinumab can be used, but its...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
